UBS Group reissued their neutral rating on shares of RELX PLC (REL.L) (LON:REL) in a research note published on Friday, Anlyst Ratings reports. They currently have a GBX 1,660 ($21.69) price target on the stock.
Several other brokerages have also commented on REL. BNP Paribas lowered RELX PLC (REL.L) to an underperform rating and dropped their price objective for the company from GBX 1,900 ($24.82) to GBX 1,650 ($21.56) in a report on Tuesday, June 30th. Credit Suisse Group reissued an outperform rating on shares of RELX PLC (REL.L) in a research note on Monday, July 27th. Barclays set a GBX 2,005 ($26.20) price objective on shares of RELX PLC (REL.L) and gave the stock a buy rating in a research report on Thursday, October 22nd. Goldman Sachs Group set a GBX 1,962 ($25.63) target price on shares of RELX PLC (REL.L) and gave the company a buy rating in a research report on Monday, October 19th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of RELX PLC (REL.L) from GBX 1,925 ($25.15) to GBX 1,850 ($24.17) and set a hold rating for the company in a research note on Friday, July 3rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. RELX PLC (REL.L) currently has an average rating of Hold and an average price target of GBX 1,902.90 ($24.86).
LON:REL opened at GBX 1,607 ($21.00) on Friday. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 373.30. RELX PLC has a 52 week low of GBX 1,382.86 ($18.07) and a 52 week high of GBX 2,109 ($27.55). The stock’s 50-day moving average price is GBX 1,724.45 and its 200-day moving average price is GBX 1,779.37. The stock has a market capitalization of $33.75 billion and a PE ratio of 24.50.
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare.
Featured Story: What is the Fibonacci sequence?
Receive News & Ratings for RELX PLC (REL.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RELX PLC (REL.L) and related companies with MarketBeat.com's FREE daily email newsletter.